Brainstorm Cell Therapeutics (BCLI)

3.06 +0.06 (2.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/16/18 *Est.)

Latest Headlines

BrainStorm Cell Therapeutics to Present at the 29th International Symposium on ALS/MND December 4, 2018 8:00 AM - Globe NewsWire Form 4 BRAINSTORM CELL THERAPEU For: Nov 30 Filed by: Schor Chen November 30, 2018 5:06 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Nov 30 Filed by: Polverino Anthony J. November 30, 2018 5:06 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Nov 30 Filed by: ARBEL IRIT November 30, 2018 5:06 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Nov 30 Filed by: Yablonka Uri November 30, 2018 5:04 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Nov 30 Filed by: TAUB MALCOLM S November 30, 2018 5:02 PM - SEC Filing Form 8-K BRAINSTORM CELL THERAPEU For: Nov 29 November 30, 2018 5:02 PM - SEC Filing Detailed Research: Economic Perspectives on Stellar Biotechnologies, MAM Software Group, EverQuote, Brainstorm Cell Therapeutics, Mid-Con Energy Partners, LP, and Staffing 360 Solutions — What Drive November 21, 2018 8:30 AM - Globe NewsWire Brainstorm Cell Therapeutics (BCLI) Announces Submission of IND for NurOwn in Progressive MS November 19, 2018 8:06 AM - StreetInsider BrainStorm Cell Therapeutics Announces Submission of IND for NurOwn® in Progressive Multiple Sclerosis November 19, 2018 8:00 AM - Globe NewsWire BrainStorm Cell Therapeutics to Present at November Clinical and Investor Conferences November 7, 2018 8:00 AM - Globe NewsWire BrainStorm Announces Financial Results for the Third Quarter of 2018 and Provides a Corporate Update October 29, 2018 8:00 AM - Globe NewsWire Form 10-Q BRAINSTORM CELL THERAPEU For: Sep 30 October 29, 2018 6:08 AM - SEC Filing BrainStorm to Announce Third Quarter Financial Results and Provide Corporate Update on Monday, October 29 October 17, 2018 8:30 AM - Globe NewsWire Form DEF 14A BRAINSTORM CELL THERAPEU For: Nov 29 October 10, 2018 8:01 AM - SEC Filing BrainStorm Poster Receives Clinical Abstract Award at NEALS Conference October 4, 2018 9:18 AM - Globe NewsWire BrainStorm Highlights Translational Data and Presentations Supporting NUROWN® Technology Platform as a Best-In-Class Strategy in ALS October 3, 2018 6:10 AM - Globe NewsWire Form 424B1 BRAINSTORM CELL THERAPEU September 28, 2018 5:50 PM - SEC Filing Form S-3/A BRAINSTORM CELL THERAPEU September 21, 2018 5:33 PM - SEC Filing Brainstorm Cell Therapeutics (BCLI) Announces New U.S. Patent for Industrial Scale Manufacturing of NurOwn September 13, 2018 7:32 AM - StreetInsider BrainStorm Granted New U.S. Patent for Industrial Scale Manufacturing of NurOwn® September 13, 2018 7:30 AM - Globe NewsWire BrainStorm to Present at FDA and Scientific Workshops Highlighting Innovation in ALS Trial Designs and Continued Progress with NurOwn® Cellular Therapy Platform September 12, 2018 8:49 AM - Globe NewsWire Full Article List